ApconiX are experts in cardiac and CNS electrophysiology, target safety assessments and in all aspects of nonclinical toxicology and DMPK project support. ApconiX was formed with the objective to give companies of all sizes access to the breadth and depth of safety expertise generally only available in large pharma. Our lab team conduct hERG and CiPA cardiac screening assays and have developed an in vitro assay to better understand seizure liability (iSLA®). We continue to carry out research in other fields relevant to efficacy and safety in the CNS. The ApconiX Safety Science Team combines toxicology expertise and advanced data science, offering customized Acuity® target safety assessments (TSAs). The team also conducts modality or asset focused reports and will support you in understanding and optimizing project safety profiles. Our consultancy team provide a flexible nonclinical drug safety and DMPK support to your discovery and development team.
Analytical Sales & Services
Analytical Sales & Services mission is to make impactful contributions to the scientific community through the design, manufacturing, and distribution of uniquely positioned scientific instrumentation and consumables. Since its founding in 1988, Analytical has been a long-standing, trusted, and collaborative partner to the research and development industry. Its core principles are building, supporting, and distributing cost effective and reliable solutions that meet the ever-developing scientific needs, worldwide. Analytical Sales & Services now serves all international markets and strives to provide solutions across all facets of science and industry. Core products developed and manufactured by Analytical Sales & Services: • Para-dox® Photoredox Catalysis & Parallel Synthesis Reaction Blocks • Lumidox® II Photon Generation Devices • Temperature Controlled Reactors (TCR) • Flow Electrolysis Assemblies • HTe-Chem Electrochemical Assemblies • EquaVAP® Blowdown Evaporators • DBS – Dried Blood Spot Card Punch • SiliGuard™ Low-bind Surface Coating • HotSleeve+™ Family of HPLC Column Heaters • FlexChrom® 1/16” Flexible Stainless Steel Tubing • TrueTaper® 96-well Collection Plates • Canary-Safe™ Solvent Safety Products Analytical also offers OEM and custom product services. Have an idea for a product or device, but not sure how to make it? Analytical Sales & Services has been helping companies develop custom solutions for over 35 years. We have a fully equipped machine shop for designing, prototyping and manufacturing. Let our intellectual property help yours! Aid in creating new products and equipment • Prototyping • Testing • Data gathering • Research and development • Full on-site engineering staff available • Domestically sourced and manufactured goods and equipment
Amgen Oncology
Amgen harnesses the best of biology and technology to make people’s lives easier, fuller and longer. We draw upon our deep knowledge of science to push beyond what’s known today. We are one of the world’s leading independent biotech companies – fighting the toughest diseases and helping millions of people globally.
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2025, Amgen was named to Fortune’s list of the World’s Most Admired Companies. | Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. | Biotech | x | Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. | Our mission is to serve patients. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Ambeed Inc.
Ambeed is a trusted research supplier supporting oncology discovery from early chemistry through translational biology worldwide. We provide high-quality building blocks, advanced intermediates, inhibitors, peptides, bio-conjugation reagents, recombinant proteins, antibodies, and custom synthesis support for academic labs, biotech companies, CROs, and pharmaceutical teams. Our portfolio is well aligned with AACR 2026’s emphasis on precision, partnership, and purpose across cancer biology, translational research, therapeutics, biomarkers, and clinical innovation. Backed by a broad in-stock inventory, Ambeed offers more than 11,000 inhibitors and agonists, 13,000 fluorinated building blocks, 7,000 amino acids and peptides, 7,000 boronic acids and esters, and 5,000 XDCs and PROTAC-related products, alongside additional core categories for hit-to-lead and oncology research. Our materials are supported by responsive service, flexible sourcing, and quality-focused manufacturing capabilities, including scale-up support up to 100 kg, a 300,000 sq. ft. facility, and a team of over 200 scientists. Stop by our booth and let’s explore how we can strengthen your ongoing pipelines.
Aladdin Scientific
About Aladdin “Aladdin: Fueling Discoveries, Advancing Science.” At Aladdin, we blend cutting-edge science with relentless progress. Established in 2009, we’re renowned for our superior reagents, ranging from chemicals and biochemicals to proteins and antibodies. With over 700 employees across global offices in the US, Germany, Ireland, Singapore, and China, and powered by three manufacturing facilities and two R&D Centers, our commitment to scientific excellence and product quality is unwavering. Our Vision Aladdin is a beacon in the technological and innovative landscape, symbolizing a future driven by scientific discovery. We believe in the transformative power of science — its ability to change societies and elevate lives. Our ethos is embodied in every product we create and every service we offer. Precision-Driven Research In the realm of research and development, precision is paramount. Our life science tools are designed for unmatched accuracy, ensuring research that’s not only efficient but also exceptionally precise. Our goal is clear and steadfast: to deliver precision-guided results and build trust through superior outcomes. | Aladdin, established in 2009, is a pioneer in scientific innovation, offering superior reagents, chemicals, and life science tools. With a global workforce of over 700 and facilities across the US, Germany, Ireland, Singapore, and China, we’re committed to excellence in research and development. Our vision is a future shaped by scientific discovery, driving societal transformation and enhancing lives. Precision and innovation lie at the heart of our operations, guiding our quest for groundbreaking solutions. Join aladdinsci.com on a journey of scientific exploration, where each advancement opens doors to a brighter, more innovative future.
Aicuris US, Inc.
“AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product, PREVYMIS®, marketed by our partner MSD, treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate pritelivir aims to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised people, an otherwise manageable infection can mean life or death. At Aicuris, we combine deep scientific knowledge with a patient-first mindset, striving to redefine the future of infection prevention and treatment.
Admera Health
Admera Health is a trusted partner in advanced genomic and bioinformatic services to empower researchers with data-driven insights. Operating in a CLIA/CLEP-certified and CAP-accredited environment using state-of-the-art NGS technology, we offer a comprehensive suite of cutting-edge solutions to deliver high-resolution insights for oncology and drug discovery. From high-throughput gene expression screening and CRISPR sequencing to multi-omic spatial mapping, our expert team equipping scientists to identify biomarkers and accelerate therapeutics with unparalleled data quality and speed.
ADMA Biologics
ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection.